🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Transplant-Related Hematologic Malignancy

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hema… Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors NCT04892823n/a1 site📍 Milwaukee Medical College of Wisconsin · Tests: Biospecimen Collection, Electronic Health Record Review, Questionnaire Administration GM-CSF With Post-Transplant Cyclophosphamide NCT04237623Phase 21 site📍 Atlanta Northside Hospital, Inc. · Tests: Sargramostim, Control Arm Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders NCT03314974Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: HSCT with TBI Regimen, HSCT with Non-TBI Regimen Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients NCT07724873Phase 1, Phase 22 sites📍 Navi Mumbai📍 Navi Mumbai Tata Memorial Centre · Tests: SWA (standardized root extract of Withania somnifera) Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy NCT03555851n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Cyclophosphamide, Specimen collection 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome NCT03670966Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Cyclophosphamide, Total-Body Irradiation, Peripheral Blood Stem … Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback NCT04640987Phase 11 site📍 Palo Alto Porteus, Matthew, MD · Tests: Allogeneic Stem Cell Transplant, CliniMACS Prodigy System, T-allo10 cells addback Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Clofarabine, Fludarabine, Busulfan, Cyclosporine-A, Mycophenolate Mofetil MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880NA1 site📍 Milwaukee Medical College of Wisconsin · Tests: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502n/a8 sites📍 La Jolla📍 San Francisco📍 Washington D.C. AIDS Malignancy Consortium · Tests: Biospecimen Collection Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome NCT07216443Phase 26 sites📍 Los Angeles📍 Tampa📍 Hackensack Orca Biosystems, Inc. · Tests: Orca-T Vitamin A and D Supplementation in Allogeneic HCT NCT06508099Phase 21 site📍 Saint Petersburg St. Petersburg State Pavlov Medical University · Tests: Vitamin A, Vitamin D3 Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia NCT06735690EARLY Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Anti-CD19-CAR CMV-specific T-lymphocytes, Biospecimen Collection, B… Response to Influenza Vaccination in Pediatric Oncology Patients NCT05384288n/a1 site📍 Memphis St. Jude Children's Research Hospital Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) NCT06462365Phase 15 sites📍 Duarte📍 Boston📍 Minneapolis Tr1X, Inc. · Tests: TRX103 CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia NCT04375631Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Cladribine, Cyclophosphamide, Cyclosporine, Cytarabine, Filgrastim Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation NCT06799195Phase 21 site📍 Omaha University of Nebraska · Tests: Attenuated-dose Cyclophosphamide, High-dose Cyclophosphamide, Sirolimus, Mycophenolate Mofetil (MMF)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy